Genome engineering using the CRISPR-Cas9 system¶
Why this mattered¶
This paper mattered because it turned CRISPR-Cas9 from a striking biological discovery into a practical genome-engineering workflow that ordinary molecular biology laboratories could use. Earlier programmable nucleases such as zinc-finger nucleases and TALENs required custom protein engineering for each target site; Ran, Hsu, Wright, Agarwala, Scott, and Zhang described a guide-RNA-based system in which retargeting Cas9 mainly meant changing a short RNA sequence. The protocol format was itself important: it specified how to design guide RNAs, clone them, deliver Cas9 and guide constructs, and assay editing outcomes, making targeted mutagenesis, deletions, and multiplex editing newly routine in mammalian cells.
The paradigm shift was not simply higher efficiency, but programmability at genome scale. Once DNA targeting could be re-specified by RNA base pairing, genome editing became modular, cheap, and scalable in a way previous tools were not. This opened the path to pooled genetic screens, rapid creation of disease models, systematic functional genomics, and engineering of cell lines and organisms with a speed that changed experimental design. Researchers could now ask questions across many loci or genes, rather than treating each edit as a bespoke engineering project.
The protocol also sat at the foundation of later CRISPR breakthroughs. Subsequent work extended the same core logic to catalytically inactive Cas9 for transcriptional control and epigenome targeting, nickases and paired guides for improved specificity, base editors, prime editors, and therapeutic genome-editing strategies. Its importance lies in codifying the operational template for CRISPR-Cas9: a broadly usable, RNA-programmed platform that transformed genome modification from a specialized technical challenge into a standard experimental capability.
Abstract¶
(no abstract available)
Related¶
- cite → RNA-Guided Human Genome Engineering via Cas9 — Both papers demonstrate Cas9 as an RNA-guided tool for targeted genome editing in human cells.
- cite → A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity — The 2013 genome-engineering protocol builds on the 2012 discovery that Cas9 is a programmable dual-RNA-guided DNA endonuclease.
- cite → Multiplex Genome Engineering Using CRISPR/Cas Systems — Both papers develop CRISPR-Cas9 for multiplex genome engineering at multiple genomic loci.